相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
L. A. Stivala et al.
CURRENT CANCER DRUG TARGETS (2012)
Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage
Vitaly Balan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Resistance to Docetaxel-Induced Apoptosis in Prostate Cancer Cells by p38/p53/p21 Signaling
Lu Gan et al.
PROSTATE (2011)
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
Matthew J. Streetly et al.
BLOOD (2010)
Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients
Palma A. Iacovazzi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
I-TASSER: a unified platform for automated protein structure and function prediction
Ambrish Roy et al.
NATURE PROTOCOLS (2010)
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment
Y. Wang et al.
CELL DEATH & DISEASE (2010)
Regulation of Prostate Cancer Progression by Galectin-3
Yi Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Eun-Woo Lee et al.
EMBO JOURNAL (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate
S. Kraljevic Pavelic et al.
CANCER GENE THERAPY (2008)
Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death
Elizabeth Garner et al.
CELL CYCLE (2008)
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing
Youngjo Kim et al.
GENES & DEVELOPMENT (2008)
Epidermal growth factor receptor expression in serous ovarian carcinoma: An immunohistochemical study with galectin-3 and cyclin D1 and outcome
Hermann Brustmann
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
FireDock: a web server for fast interaction refinement in molecular docking
Efrat Mashiach et al.
NUCLEIC ACIDS RESEARCH (2008)
Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3
Armando Bartolazzi et al.
PLOS ONE (2008)
Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer
Axel S. Merseburger et al.
PROSTATE (2008)
APC/CCdc20 controls the ubiquitin-mediated degradation of p21 in prometaphase
Virginia Amador et al.
MOLECULAR CELL (2007)
BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK
Stayce E. Beck et al.
CELLULAR SIGNALLING (2007)
Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells
H Van Le et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PatchDock and SymmDock: servers for rigid and symmetric docking
D Schneidman-Duhovny et al.
NUCLEIC ACIDS RESEARCH (2005)
Galectin-3 expression in non-small cell lung carcinoma
F Puglisi et al.
CANCER LETTERS (2004)
Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry
J Feilchenfeldt et al.
MODERN PATHOLOGY (2003)
Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase
G Bornstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?
O Coqueret
TRENDS IN CELL BIOLOGY (2003)
Are p27 and p21 Cytoplasmic Oncoproteins?
Mikhail V. Blagosklonny
CELL CYCLE (2002)
Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP
JA Ellerhorst et al.
PROSTATE (2002)
A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome
R Touitou et al.
EMBO JOURNAL (2001)
Galectin-3 mediates genistein-induced G2/M arrest and inhibits apoptosis
HM Lin et al.
CARCINOGENESIS (2000)
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination
RJ Sheaff et al.
MOLECULAR CELL (2000)